Join the club for FREE to access the whole archive and other member benefits.

Nature Immunology

Scientific journal publishing the highest quality research in all areas of immunology

Nature Immunology is a multidisciplinary journal that publishes papers of the highest quality and significance in all areas of immunology. Priority is given to work that provides translational and/or fundamental insight into the workings of the immune system. Areas covered include, but are not limited to, innate immunity and inflammation; development; immune receptors, signaling and apoptosis; antigen presentation; gene regulation and recombination; cellular and systemic immunity; vaccines; immune tolerance; autoimmunity; tumor immunology, and microbial immunopathology.

Nature Immunology places its highest priority on fair and rapid review and speedy publication. Decisions on whether to send a manuscript out for peer review are normally made within two working days of receipt and decisions about publication are typically made within two days of receipt of the referees' reports.

Visit website: https://www.nature.com/ni/

 NatImmunol

See also

Nature

Scientific journal covering research from a variety of academic disciplines, mostly in science and technology

Details last updated 21-Jan-2020

Nature Immunology News

Celllens decodes tumor cells

Celllens decodes tumor cells

Massachusetts Institute of Technology (MIT) - 11-Jul-2025

AI tool finds hidden immune cell types to improve cancer diagnosis and targeted therapies

Blind mole rats use junk DNA to trigger self-destruction of cancer cells

Blind mole rats use junk DNA to trigger self-destruction of cancer cells

The Scientist - 30-Sep-2021

Retrotransposons activate immune response against precancerous cells - may have implications in humans

A novel approach unlocked a gene's purpose on immune system

A novel approach unlocked a gene's purpose on immune system

Medical Xpress - 09-Nov-2020

Study in mice and humans found CRELD1 gene's role in immune cell aging

Inhibiting p38 MAPK rejuvenates resolution response in elderly

Inhibiting p38 MAPK rejuvenates resolution response in elderly

Lifespan.io (LEAF) - 15-Apr-2020

A new perspective on mitigating the effects of inflammaging, promoting health in older people

'One-size-fits-all' new cancer treatment

'One-size-fits-all' new cancer treatment

BBC - 20-Jan-2020

Good to see a new approach to tackle cancer, but this is a long way from trials